SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Conference Call May 7, 2024 8:00 AM ET Company Participants Kellen Sanger - Head, Strategy and IR Jurgi Camblong - Co-Founder and CEO Ross Muken - CFO and COO Conference Call Participants Conor McNamara - RBC Capital Markets Yuko Mihara - Morgan Stanley Vivian Bais - BTIG Operator Good day everyone. My name is Jamie and I'll be your conference operator today. At this time, I'd like to welcome everyone to the SOPHiA GENETICS First Quarter 2024 Earnings Confer ...

:°: SOPHiA ·°·: GENETICS™ No offer to sell or buy Market and industry data © SOPHiA GENETICS 2024 3 4 © SOPHiA GENETICS 2024 For decades, health data has been produced in silos © SOPHiA GENETICS 2024 SOPHiA DDM™ is a decentralized analytics platform which computes © SOPHiA GENETICS 2024 $25B $15B Generating insights from multimodal data to help Clinicians with screening, early detection, diagnosis, therapy selection, and monitoring The decentralized, cloud-based analytics platform at the center of it all No ...

SOPHiA GENETICS SA (SOPH) closed the last trading session at $5.05, gaining 3.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.33 indicates a 65% upside potential.The average comprises three short-term price targets ranging from a low of $7 to a high of $10, with a standard deviation of $1.53. While the lowest estimate indicates an increase of 38.6% from the current price leve ...

dated as of May 2, 2024 among SOPHiA GENETICS SA as Borrower, The Guarantors From Time To Time Party Hereto, as Guarantors, The Lenders From Time To Time Party Hereto, as Lenders, Execution Version Credit Agreement and Guaranty and Perceptive Credit Holdings IV, LP, as the Administrative Agent and as a Lender 4894-2985-1820 7040231 #98195096v26 Table of Contents Section Heading Page Schedules: | Schedule | 1 | — | Commitments and Warrant Shares | | --- | --- | --- | --- | | Schedule | 2 | — | Notice Address ...

BOSTON and ROLLE, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced that Chief Financial Officer and Chief Operating Officer, Ross Muken, will present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City on Tuesday, May 14, 2024, at 3:35 p.m. EDT. The presentation will be webcast live on the SOPHiA GENETICS Investor Relations website. Additionally, a replay will be available on the w ...

BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal year 2024 before U.S. markets open on Tuesday, May 7, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET. The call will be webcast live on th ...

BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal year 2024 before U.S. markets open on Tuesday, May 7, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET. The call will be webcast live on th ...

Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout AfricaBOSTON and ROLLE, Switzerland, April 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDM™. Syndicate Bio is the first lab in Africa to adopt the MSK-ACCESS® assay via the SOPHiA DDM™ Platform, and the ...

European-based Unilabs has deployed the SOPHiA DDM™ Platform across its network in Switzerland to support cancer diagnostics and treatment BOSTON and ROLLE, Switzerland, April 17, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Unilabs, one of the largest diagnostic providers in Europe, and the only provider to offer laboratory, imaging and pathology specialties within one group, is live on the SOPHiA DDM™ Platfo ...

The companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland, April 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced a strategic partnership with Strand Life Sciences, a pioneer in bioinformatics and diagnostics, to deliver innovative solutions that will fuel the use of precision medicine globally. The new collaboration will leverage ...